GATA2 and myelodysplastic syndrome: It revealed a striking age-dependent pattern of GATA2-MDS where, by age 6 years, only 7.2% of the affected cohort developed MDS, increasing to 45.5% by age 12 years before reaching 100% by the age of 19 years (Fig. 1D).